News & Articles

Results per page

Selected Filters:

Rockland Immunochemicals Clear Filters

Industry News

CEDARVILLE Engineering Group & Rockland Immunochemicals, Inc. Collaborate on a 3D Bioprinting Discovery Project

11 Jan 2018

Industry News

The Binding Site & Rockland Immunochemicals Enter into Distribution Agreement

25 Apr 2016

Industry News

Formula Pharmaceuticals and Rockland Immunochemicals Enter into a Collaboration to Develop C.I.K. CAR™ Immunotherapy Pipeline for the Treatment of Cancer

22 Feb 2016

Editorial Article

Chromatin Immunoprecipitation: 10 Technical Tips for Success

19 Feb 2016

Editorial Article

Flow Cytometry: Five Technical Tips

16 Feb 2016

Product News

Rockland Immunochemicals, Inc. Introduces Melanoma Cell Lines in Collaboration with The Wistar Institute

1 Feb 2016

Industry News

Rockland Hosts Meeting on STEM Job Creation with PA Officials and Regional Organizations

14 Sept 2015

Industry News

The Wistar Institute and Rockland Immunochemicals Announce Partnership in Discovery and Research

13 Jul 2015

Industry News

Rockland Immunochemicals to Develop Synthetic Antibodies for Modified RNA Detection and Quantitation with $225,000 SBIR Funded Grant

18 Nov 2014

Editorial Article

Western Blotting: 10 Technical Tips for Success

8 Sept 2014

Industry News

Rockland Immunochemicals, Inc. Awarded SBIR Funding to Develop Antibody-Based Point of Care Device for the Diagnosis of Sickle Cell Disease

7 Sept 2014

Industry News

Rockland Immunochemicals Expands Laboratories to Keep Pace with Growth

28 May 2014

Industry News

Rockland Immunochemicals Commits $1 Million to Joy Cappel “Young Investigator Awards”

7 Apr 2014

Product News

New Antibody Collaboration for Cancer Research

27 Jan 2011

Product News

Rockland Immunochemicals announces the successful use of a number of its antibody reagents on clinical samples in studies being conducted by the Swedish Human Protein Atlas program

3 May 2007

Product News

Rockland Immunochemicals, Inc. offers over 2800 target-specific antibodies to validate knockdown protein expression

3 May 2007

News & Articles

Articles Filter

Search

Selected Filters:

CEDARVILLE Engineering Group & Rockland Immunochemicals, Inc. Collaborate on a 3D Bioprinting Discovery Project

The Binding Site & Rockland Immunochemicals Enter into Distribution Agreement

Formula Pharmaceuticals and Rockland Immunochemicals Enter into a Collaboration to Develop C.I.K. CAR™ Immunotherapy Pipeline for the Treatment of Cancer

Chromatin Immunoprecipitation: 10 Technical Tips for Success

Flow Cytometry: Five Technical Tips

Rockland Immunochemicals, Inc. Introduces Melanoma Cell Lines in Collaboration with The Wistar Institute

Rockland Hosts Meeting on STEM Job Creation with PA Officials and Regional Organizations

The Wistar Institute and Rockland Immunochemicals Announce Partnership in Discovery and Research

Rockland Immunochemicals to Develop Synthetic Antibodies for Modified RNA Detection and Quantitation with $225,000 SBIR Funded Grant

Western Blotting: 10 Technical Tips for Success

Rockland Immunochemicals, Inc. Awarded SBIR Funding to Develop Antibody-Based Point of Care Device for the Diagnosis of Sickle Cell Disease

Rockland Immunochemicals Expands Laboratories to Keep Pace with Growth

Rockland Immunochemicals Commits $1 Million to Joy Cappel “Young Investigator Awards”

New Antibody Collaboration for Cancer Research

Rockland Immunochemicals announces the successful use of a number of its antibody reagents on clinical samples in studies being conducted by the Swedish Human Protein Atlas program

Rockland Immunochemicals, Inc. offers over 2800 target-specific antibodies to validate knockdown protein expression

News & Articles

Articles FilterArticles Filter

Search

Selected Filters:

CEDARVILLE Engineering Group & Rockland Immunochemicals, Inc. Collaborate on a 3D Bioprinting Discovery Project

The Binding Site & Rockland Immunochemicals Enter into Distribution Agreement

Formula Pharmaceuticals and Rockland Immunochemicals Enter into a Collaboration to Develop C.I.K. CAR™ Immunotherapy Pipeline for the Treatment of Cancer

Chromatin Immunoprecipitation: 10 Technical Tips for Success

Flow Cytometry: Five Technical Tips

Rockland Immunochemicals, Inc. Introduces Melanoma Cell Lines in Collaboration with The Wistar Institute

Rockland Hosts Meeting on STEM Job Creation with PA Officials and Regional Organizations

The Wistar Institute and Rockland Immunochemicals Announce Partnership in Discovery and Research

Rockland Immunochemicals to Develop Synthetic Antibodies for Modified RNA Detection and Quantitation with $225,000 SBIR Funded Grant

Western Blotting: 10 Technical Tips for Success

Rockland Immunochemicals, Inc. Awarded SBIR Funding to Develop Antibody-Based Point of Care Device for the Diagnosis of Sickle Cell Disease

Rockland Immunochemicals Expands Laboratories to Keep Pace with Growth

Rockland Immunochemicals Commits $1 Million to Joy Cappel “Young Investigator Awards”

New Antibody Collaboration for Cancer Research

Rockland Immunochemicals announces the successful use of a number of its antibody reagents on clinical samples in studies being conducted by the Swedish Human Protein Atlas program

Rockland Immunochemicals, Inc. offers over 2800 target-specific antibodies to validate knockdown protein expression

Articles Filter